B-cell depletion with obinutuzumab for the treatment of IgG4-related disease
- PMID: 37481424
- DOI: 10.1016/j.ejim.2023.07.019
B-cell depletion with obinutuzumab for the treatment of IgG4-related disease
Keywords: Obinutuzumab is a safe and effective treatment for IgG4-RD.
Comment on
-
Obinutuzumab as treatment for ANCA-associated vasculitis.Rheumatology (Oxford). 2022 Aug 30;61(9):3814-3817. doi: 10.1093/rheumatology/keab916. Rheumatology (Oxford). 2022. PMID: 34958343 Review.
-
Membranous nephropathy associated with immunoglobulin G4-related disease successfully treated with obinutuzumab.Clin Kidney J. 2021 Dec 8;15(3):564-566. doi: 10.1093/ckj/sfab250. eCollection 2022 Mar. Clin Kidney J. 2021. PMID: 35211311 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous